Letrolive 2.5mg Tablet

Letrolive 2.5mg Tablet is an anti-cancer medication belonging to the aromatase inhibitor class. It is indicated as supportive therapy following primary treatment or as first-line therapy for postmenopausal women with early and advanced breast cancer whose tumours are hormone receptor-positive. Because elevated estrogen levels are associated with breast cancer development, this medicine lowers estrogen levels by inhibiting aromatase, the enzyme responsible for estrogen synthesis. This action aims to slow or halt cancer growth and spread to other body sites, consistent with clinical use of Letrolive 2.5mg. If you have not completed menopause, inform your doctor, as this medicine is ineffective in premenopausal women. Since Letrolive 2.5mg reduces female reproductive hormone levels, it is contraindicated in menstruating women due to potential fertility complications. Cholesterol level monitoring is important, as this medication may elevate cholesterol. Additionally, Letrolive 2.5mg may decrease bone mineral density; regular monitoring of bone parameters is recommended in consultation with your physician. During Letrolive 2.5mg treatment, effective contraception should be used and continued for at least 3 weeks following the final dose. Alternative aromatase inhibitors may be available if Letrolive 2.5mg is unsuitable for you, though consultation with your doctor is essential before considering alternatives.

First and second-line treatment of postmenopausal women with hormone receptor-positive breast cancer. Supportive to standard treatment for postmenopausal women with early breast cancer. Treatment for unknown advanced breast cancer in postmenopausal women. Extended supportive therapy for postmenopausal women with early breast cancer who have already taken other anti-cancer medication.

The growth of some cancers of breasts are stimulated by estrogens. Letrolive 2.5mg Tablet is a nonsteroidal compound that inhibits estrogen production by blocking the enzyme aromatase. This medicine reduces the tumor size and stops or slows the progression of the disease, avoiding the reoccurring of early-stage breast cancer and improving the survival rate.

It is advised to consume Letrolive 2.5mg Tablet exactly as your doctor prescribes. It can be consumed with or without food and should be swallowed with a glass of water. Letrolive 2.5mg Tablet can be taken with or without food. It is better to take the tablet at a fixed time. Do not break, chew or crush the tablet.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Letrolive 2.5mg side effects are Serious Decreased red blood cells Decreased bone mineral density Fluid buildup in lungs Common Swelling in the face, eyes, feet, and legs Hot sweats and excessive sweating Hypercholesterolemia (high cholesterol) Constipation Heart papilation Hypertension Diarrhea Loss of appetite Nausea and Vomiting Muscle pain, bone pain, and joint stiffness Dizziness, tiredness, and sleepiness Breathing difficulty Arthralgia.